Research Overview

HGH Fragment 176-191 (AOD-9604) corresponds to the C-terminal 16–amino-acid region of human growth hormone. In experimental models it is used to investigate GH-fragment signaling, lipolytic pathways in adipocytes and metabolic regulation, while avoiding direct activation of full-length GH receptor mitogenic pathways. All studies remain strictly within laboratory/experimental contexts without therapeutic claims.

Primary Research Areas

• Lipolysis & adipocyte metabolism: Experimental models assessing hormone-sensitive lipase activation, fatty acid release and triglyceride turnover in adipose tissue.
• Growth hormone fragment signaling: In vitro work on downstream pathways modulated by the 176-191 fragment compared with full-length GH, including cAMP and MAPK-related cascades.
• Metabolic & energy-balance research: Laboratory studies exploring body-composition and energy-expenditure pathways in controlled animal and cell-based models.